|
Cerezo-Manchado JJ, Roldan V, Rosafalco M, Anton AI, Arroyo AB, Garcia-Barbera N, Martínez AB, Padilla J, Corral J, Vicente V, Gonzalez-Conejero R. Effect of VKORC1, CYP2C9 and CYP4F2 genetic variants in early outcomes during acenocoumarol treatment. Pharmacogenomics. 2014 May;15(7):987-96. doi: 10.2217/pgs.13.232. PubMed PMID: 24956252.
AÑO: 2014; IF: 3.218
|
24956252
|
Braza-Boïls A, Salloum-Asfar S, Marí-Alexandre J, Arroyo AB, González-Conejero R, Barceló-Molina M, García-Oms J, Vicente V, Estellés A, Gilabert-Estellés J, Martínez C. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis. Hum Reprod. 2015 Oct;30(10):2292-302. doi: 10.1093/humrep/dev204. PubMed PMID: 26307093.
AÑO: 2015; IF: 4.621
|
|
Cerezo-Manchado JJ, Roldán V, Corral J, Rosafalco M, Antón AI, Padilla J, Vicente V, González-Conejero R. Genotype-guided therapy improves initial acenocoumarol dosing. Results from a prospective randomised study. Thromb Haemost. 2016 Jan;115(1):117-25. doi: 10.1160/TH14-09-0814. Epub 2015 Nov 5. PubMed PMID: 26538428.
AÑO: 2016; IF: 5.627
|
|
Jover E, Marín F, Quintana M, Pérez-Andreu J, Hurtado JA, Rodríguez C, Martínez-González J, González-Conejero R, Valdés M, Hernández-Romero D. CALU polymorphism A29809G affects calumenin availability involving vascular calcification. J Mol Cell Cardiol. 2015 May;82:218-27. doi: 10.1016/j.yjmcc.2015.03.015. PubMed PMID: 25823396.
AÑO: 2015; IF: 4.874
|
|
Salloum-Asfar S, Arroyo AB, Teruel-Montoya R, García-Barberá N, Roldán V, Vicente V, Martínez C, González-Conejero R. MiRNA-Based Regulation of Hemostatic Factors through Hepatic Nuclear Factor-4 Alpha. PLoS One. 2016 May 2;11(5):e0154751. doi: 10.1371/journal.pone.0154751. eCollection 2016. PubMed PMID: 27135744; PubMed Central PMCID: PMC4852917.
AÑO: 2016; IF: 2.806
|